Clarityne are drugs that alter histamine effects by decreasing the histamine levels or blocking the histamine receptors. Generally, the histamine 1 or H1 receptor is blocked to minimize the effects of the histamine secreted. It is mostly used to treat any allergic response caused by the hyper secretion of histamine, as in the case of allergic conjunctivitis along with temporary relief in minor allergic symptoms of the eye.
The major factors that drive the clarityne market growth are increasing incidences of allergic conditions that trigger the hyper production of histamine, unhealthy lifestyle, and increase in environmental pollution. However, increased preference for complementary and alternative medicine (CAM) & side effects associated with drugs such as drowsiness restrain the market growth. In addition, continuous research and development in the field of clarityne drugs is expected to provide lucrative opportunities for the market.
The report segments the clarityne market based on product, end user, and region. Based on product, the market is segmented into loratadine tablet, loratadine capsule, and loratadine syrup. Based on end users, the market is segmented into adult and pediatric. Based on region, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players of the market included in the report are Merck and Co. Inc., Bayer AG, Perrigo company plc., Sun Pharmaceutical Industries Ltd., Apotex Inc, Pfizer Inc., Sandoz International GmbH, Mylan N.V., SL Pharm Labs, and Cadila Pharmaceuticals.
- The study provides an in-depth analysis of the clarityne market, with current trends and future estimations to elucidate imminent investment pockets.
- It presents a quantitative analysis from 2016 to 2023 to enable stakeholders to capitalize on prevailing market opportunities.
- Extensive analysis of the market by product type elucidates various forms of clarityne drugs.
- Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.
- By region, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Clarityne Market Key Segmentation:
- Loratadine Tablet
- Loratadine Capsule
- Loratadine Syrup
By End User
- North America
- Rest of Europe
- Rest of Asia-Pacific
- Saudi Arabia
- South Africa
- Rest of LAMEA